3T Biosciences 27-slide pitch deck to raise $40M Series A

T Biosciences
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

27
every slide · same image gating as the playbook
01
Slide 1
The background features a stylized cell with binary code overlay, suggesting a computational biology or data-driven approach to biosciences.front_matter
02
summarize
03
The slide uses a vertical timeline-style list to present core value propositions.summarize
04
The slide highlights academic pedigree, founder accolades, and institutional support.cite_precedent
07
The slide highlights academic prestige and industry leadership of the SAB members.other
08
transition
09
The diagram illustrates a process flow from patient cohort to target identification and candidate selection.present_solution
Open slide detailBeat · SolutionLoop · Jobs To Be Done
10
Uses a funnel diagram to visualize library size (diversity) across different companies.compare_peers
Open slide detailBeat · SolutionLoop · Jobs To Be Done
11
The slide uses a process flow diagram to illustrate the company's proprietary platform.present_solution
Open slide detailBeat · SolutionLoop · Jobs To Be Done
12
The slide uses a hub-and-spoke diagram to illustrate how a single platform technology enables multiple downstream applications.present_solution
Open slide detailBeat · SolutionLoop · Jobs To Be Done
13
The slide uses a callout structure to link the molecular visualization to the value proposition list.present_solution
Open slide detailBeat · SolutionLoop · Jobs To Be Done
14
The slide uses a three-column layout to represent a linear process flow.present_solution
Open slide detailBeat · SolutionLoop · Jobs To Be Done
15
transition
16
The slide uses a contrast-pair framework to highlight the limitation of current therapies (~25% targetable) versus the expanded capability of the company's platpresent_solution
17
frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
18
The slide uses a comparative case study format to validate the platform's efficacy in protein engineering.present_solution
Open slide detailBeat · AgitateLoop · Cost Of Inaction
19
The slide uses two line charts to demonstrate the efficacy and specificity of engineered TCRs compared to a benchmark.show_traction
Open slide detailBeat · AgitateLoop · Cost Of Inaction
20
transition
21
The slide uses a process flow diagram to illustrate the company's proprietary platform.present_solution
22
The slide illustrates a data-driven platform architecture connecting patient samples/TCRs to specific tumor types and HLA classes.present_solution
23
The slide uses a funnel diagram for the first process and a circular process diagram for the second.present_solution
24
The slide uses a combination of process flow, a pyramid framework for expansion, and scientific data plots (dot plot, histogram, and bar chart) to validate the show_traction
25
transition
26
present_solution
27
summarize